News. Analysis. Insight.™ - 100 Years of Journalistic Excellence

Affymetrix develops, manufactures, sells and services consumables and systems for genetic analysis in the life sciences and clinical healthcare market. Co.'s GeneChip microarray platform includes: disposable deoxyribonucleic acid probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. Co. also provides microarray technology that includes licenses for fabricating, scanning, collecting and analyzing results from complementary technologies.

Industry	Health
Sector	Biotechnology
# of Employees	1,128
Shares Outstanding	71.1M
Market Cap	382.3M
Enterprise Value	1.7B

52-Week High	$10.06
52-Week Low	$1.78
P/E Ratio	-1.07
EPS	-$5.04/shr
Dividend	-
Yield	-

Mr. John C. Batty

Chief Financial Officer; Executive Vice President

Dr. Stephen P.A. Fodor Ph.D.

Executive Chairman

Mr. John F. Runkel

Executive Vice President; General Counsel

Mr. Kevin M. King

President; Chief Executive Officer

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs